Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kazia Therapeutics Limited

1.18
+0.334939.63%
Post-market: 1.11-0.0697-5.91%19:59 EST
Volume:4.50M
Turnover:5.61M
Market Cap:6.60M
PE:-0.17
High:1.44
Open:0.8107
Low:0.8000
Close:0.8451
Loading ...

Maxim starts Kazia Therapeutics at Buy amid ‘positive’ GBM study data

TIPRANKS
·
06 Feb

Kazia Therapeutics Ltd : Maxim Group Initiates Coverage With Buy Rating; Target Price $3

THOMSON REUTERS
·
06 Feb

Is Kazia Therapeutics (KZIA) One of the Best ASX Stocks to Buy According to Hedge Funds?

Insider Monkey
·
31 Jan

Sector Update: Health Care Stocks Gain Thursday

MT Newswires Live
·
31 Jan

Kazia Therapeutics Shares Rise After Breast Cancer Treatment Trial Announced

MT Newswires Live
·
30 Jan

Kazia Therapeutics Announces the Launch of a Groundbreaking Trial With Paxalisib in Combination With Immunotherapy in Women With Advanced Breast Cancer

THOMSON REUTERS
·
30 Jan

Kazia Therapeutics announces the launch of a groundbreaking trial with paxalisib in combination with immunotherapy in women with advanced breast cancer

PR Newswire
·
30 Jan

Why Kazia Therapeutics (KZIA) Is Among the Best Australian Stocks to Buy Now?

Insider Monkey
·
27 Jan

Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering

THOMSON REUTERS
·
15 Jan

Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering

PR Newswire
·
15 Jan

Kazia Therapeutics Launches $2 Million Registered Direct Offering

MT Newswires Live
·
11 Jan

Kazia Therapeutics to sell 1.33M ADS at $1.50 in registered direct offering

TIPRANKS
·
10 Jan

Kazia Therapeutics Announces $2.0 Million Registered Direct Offering

THOMSON REUTERS
·
10 Jan

Kazia Therapeutics Announces $2.0 Million Registered Direct Offering

PR Newswire
·
10 Jan

Sector Update: Health Care Stocks Lower in Afternoon Trading

MT Newswires Live
·
01 Jan

Why Is Brain Cancer-Focused Kazia Therapeutics Stock Trading Lower On Tuesday?

Benzinga
·
01 Jan